Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Varonis Systems (VRNS) Reiterated at Overweight by Cantor Fitzgerald: Acquiring AI Trust
-
Zscaler (ZS) Reiterated at Overweight by Cantor Fitzgerald: Acquisition Tailwinds Likely
-
CrowdStrike Holdings (CRWD) Reiterated at Overweight by Cantor Fitzgerald
-
Molina Healthcare (MOH) PT Lowered to $144 at Cantor Fitzgerald: 'Difficult Name to Own'
-
Centene (CNC) Reiterated at Neutral by Cantor Fitzgerald: 'Warming up to 2026 Guide'
-
IonQ (IONQ) Reiterated at Overweight by Cantor Fitzgerald: Management Remains Optimistic
-
Eve Holding (EVEX) Reiterated at Overweight by Cantor Fitzgerald: Unveiling New Aircraft
-
Aurora Innovation (AUR) Reiterated at Overweight by Cantor Fitzgerald: '27 SOP a Catalyst
-
Rivian Automotive (RIVN) Reiterated at Neutral by Cantor Fitzgerald Ahead of Q4 Earnings
-
Ventas (VTR)Reiterated at Overweight by Cantor Fitzgerald: Double-Digit OSG Not Forever
-
COPT Defense Properties (CDP) PT Raised to $37 at Cantor Fitzgerald
-
Cantor Equity Partners VI completes $115 million IPO on Nasdaq
-
Cantor Equity Partners VI, Inc. Announces Closing of $115 Million Initial Public Offering
-
Form 8-K Cantor Fitzgerald Income For: Feb 06
-
American Drive Acquisition Company Announces the Separate Trading of Its Class A Ordinary Shares and Warrants, Commencing on February 9, 2026
-
CleanSpark Inc. (CLSK) PT Lowered to $17 at Cantor Fitzgerald
-
Cantor Fitzgerald Reiterates Overweight Rating on Microchip Technology (MCHP)
-
Reddit (RDDT) PT Lowered to $170 at Cantor Fitzgerald Following Q4 Print
-
Amazon.com (AMZN) PT Lowered to $250 at Cantor Fitzgerald
-
Impinj Inc (PI) PT Lowered to $170 at Cantor Fitzgerald
-
IREN Ltd. (IREN) PT Lowered to $82 at Cantor Fitzgerald, 'They Have the Power & Demand; Pullback a Buying Opp'
-
Cantor Fitzgerald Starts Jumia Technologies (JMIA) at Overweight
-
Veradermics completes $294.8 million IPO with full underwriter option exercise
-
Veradermics Announces Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares in Initial Public Offering
-
Iron Horse Acquisition II Corp. Announces the Separate Trading of its Ordinary Shares and Rights Commencing February 6, 2026
-
Cantor Fitzgerald Reiterates Overweight Rating on Abbvie (ABBV)
-
Cantor Fitzgerald Reiterates Overweight Rating on Tenable (TENB)
-
Cantor Fitzgerald Reiterates Overweight Rating on Alphabet (GOOGL)
-
Uber Inc. (UBER) PT Lowered to $92 at Cantor Fitzgerald
-
Snap Inc (SNAP) PT Lowered to $7 at Cantor Fitzgerald
-
Powell Industries (POWL) PT Raised to $481 at Cantor Fitzgerald
-
Cantor Fitzgerald Upgrades DigitalOcean (DOCN) to Overweight
-
Cantor Fitzgerald Starts Karyopharm Therapeutics (KPTI) at Overweight
-
Form 3 Cantor Equity Partners For: Feb 04 Filed by: CANTOR FITZGERALD, L. P.
-
Cantor Equity Partners VI prices $100 million IPO at $10 per share
-
Cantor Equity Partners VI, Inc. Announces Pricing of $100 Million Initial Public Offering
-
Amgen (AMGN) PT Raised to $350 at Cantor Fitzgerald
-
Varonis Systems (VRNS) PT Lowered to $35 at Cantor Fitzgerald
-
monday.com Ltd. (MNDY) PT Lowered to $148 at Cantor Fitzgerald
-
Western Digital Corp. (WDC) PT Raised to $420 at Cantor Fitzgerald
-
Seagate Technology (STX) PT Raised to $650 at Cantor Fitzgerald
-
Cantor Fitzgerald Reiterates Overweight Rating on JFrog (FROG)
-
CytomX Therapeutics (CTMX) PT Raised to $10 at Cantor Fitzgerald
-
Teradyne (TER) PT Raised to $330 at Cantor Fitzgerald
-
UBS reports net profit of USD 1.2bn in 4Q25 and USD 7.8bn in FY25; increases dividend by 22% YoY; confirms 2026 targets and sets ambitions for 2028 (Ad hoc announcement pursuant to Article 53 of the S
-
Veradermics prices upsized IPO at $17 per share, raising $256.3 million
-
Veradermics Announces Pricing of Upsized Initial Public Offering
-
Form 8-K Cantor Fitzgerald Income For: Jan 28
-
Investview Strengthens Board with New Appointment of Robert Verdun to Board of Directors
-
Veradermics IPO expected to price at top of $14-$16 range

